Dr. Cassie Mae Argenbright is currently completing a T32 postdoctoral fellowship in the Department of Psychology and Biobehavioral Sciences at St. Jude Children’s Research Hospital.
Argenbright received her BS in psychology with a minor in neuroscience from the University of Texas at Arlington in 2019. She also completed both her Master’s in 2021 and PhD in 2023 in the Experimental Psychology, Health and Neuroscience program at the University of Texas at Arlington.
Argenbright has previously served as an Adjunct Research Faculty member at Parker University in Dallas, Texas. She served as an Instructor of Record at the University of Texas at Arlington from 2020-23, with training in community-engaged teaching as a Service-Learning Faculty Fellow and has also held numerous other mentorship and fellowship positions during her PhD tenure.
While at the University of Texas at Arlington, Argenbright received several fellowships and scholarships: Department of Psychology Scholarship (2019), Dean’s Doctoral College of Science Fellowship (2020-2023), Psychology STEM Doctoral Fellowship (2021), College of Science Dean’s Excellence Scholarship (2022-2023), and Center for Service-Learning Faculty Fellowship (2023). She has been honored as an I-Engage Graduate Student Mentor (2022-2023) for her student mentorship. For her research, she has been awarded the IASP Trainee Development Award (2022), Honorable Poster Mention from the Texas Psychological Association (2023), and is a nominee for the Donald B. Lindsley Prize in Behavioral Neuroscience (2024).
Argenbright’s research focuses on chronic pain and neurobehavioral outcomes in pediatric cancer and survivorship. She is passionate about chronic pain research, particularly in understudied disorders and vulnerable populations. Her previous work focused on identifying the underlying biological and behavioral mechanisms of pain disorders from a preclinical standpoint to inform translational science. Her furthered interest in clinical research stems from a desire to be trained in the full spectrum of translational research, as well as to effectively design clinical interventions for chronic pain management.
By joining the Clinical Investigations program, Argenbright seeks to gain robust training in clinical research to compliment her background in preclinical chronic pain research. Additionally, she aims to develop further skills in biostatistics, epidemiological approaches, and translational neuroscience.
Hometown: Dallas, TX
Education:
PhD, Experimental Psychology, Health and Neuroscience – University of Texas at Arlington
MS, Experimental Psychology, Health and Neuroscience – University of Texas at Arlington
BS, Psychology (minor in neuroscience) – University of Texas at Arlington
Publications:
Argenbright CM, Bertlesman AM, Russell IM, Greer TL, Peng YB, & Fuchs PN. (2024). The Fibromyalgia Pain Experience: A Scoping Review of the Preclinical Evidence for Replication and Treatment of the Affective and Cognitive Pain Dimensions. Biomedicines 12(4), 778.
Argenbright CM, Bland MK, Michener SL, Wilson JR, & Fuchs PN. (2023). Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model. Frontiers in Pain Research 4, 1097457.
McNabb CT, Salcido CA, Argenbright CM, Fuchs PN. (2023). The Role of the Rat Infralimbic Cortex in Distraction Analgesia. Behavioural Brain Research.